Antitumor effects of L-BLP25 Antigen-Specific tumor immunotherapy in a novel human MUC1 transgenic lung cancer mouse model

Por Wurz, Gregory T, Gutierrez, Audrey M, Greenberg, Brittany E, Vang, Daniel P, Griffey, Stephen M, Kao, Chiao-Jung, Wolf, Michael, DeGregorio, Michael W
Publicado em 2013

Epidermal Growth Factor Receptor Exon 20 Mutation Increased in Post-Chemotherapy Patients with Non-Small Cell Lung Cancer Detected with Patients' Blood Samples

Por Wang, Ying, Bao, Wenlong, Shi, Hua, Jiang, Chuming, Zhang, Yongjun
Publicado em 2013

Radiological differential diagnosis between fibrosis and recurrence after stereotactic body radiation therapy (SBRT) in early stage non-small cell lung cancer (NSCLC)

Por Frakulli, Rezarta, Salvi, Fabrizio, Balestrini, Damiano, Palombarini, Marcella, Akshija, Ilir, Cammelli, Silvia, Morganti, Alessio Giuseppe, Zompatori, Maurizio, Frezza, Giovanni
Publicado no Transl Lung Cancer Res (2017)

The P38α rs3804451 Variant Predicts Chemotherapy Response and Survival of Patients with Non–Small Cell Lung Cancer Treated with Platinum-Based Chemotherapy()

Por Jia, Ming, Xu, Yuan, Zhu, Meiling, Wang, Mengyun, Sun, Menghong, Qian, Ji, Chang, Jianhua, Wei, Qingyi
Publicado no Transl Oncol (2016)

mRNA expression levels and genetic status of genes involved in the EGFR and NF-κB pathways in metastatic non-small-cell lung cancer patients

Por Santarpia, Mariacarmela, Magri, Ignacio, Sanchez-Ronco, Maria, Costa, Carlota, Molina-Vila, Miguel Angel, Gimenez-Capitan, Ana, Bertran-Alamillo, Jordi, Mayo, Clara, Benlloch, Susana, Viteri, Santiago, Gasco, Amaya, Mederos, Nuria, Carcereny, Enric, Taron, Miquel, Rosell, Rafael
Publicado em 2011

High EGFR copy number predicts benefits from tyrosine kinase inhibitor treatment for non-small cell lung cancer patients with wild-type EGFR

Por Wang, Fang, Fu, Sha, Shao, Qiong, Zhou, Yan-Bin, Zhang, Xiao, Zhang, Xu, Xue, Cong, Lin, Jian-Guang, Huang, Li-Xia, Zhang, Li, Zhang, Wei-Min, Shao, Jian-Yong
Publicado em 2013

Thymidylate synthase polymorphisms in genomic DNA as clinical outcome predictors in a European population of advanced non-small cell lung cancer patients receiving pemetrexed

Por Arévalo, Estefanía, Castañón, Eduardo, López, Inés, Salgado, Josefa, Collado, Víctor, Santisteban, Marta, Rodríguez-Ruiz, María, Martín, Patricia, Zubiri, Leire, Patiño-García, Ana, Rolfo, Christian, Gil-Bazo, Ignacio
Publicado em 2014

YangZheng XiaoJi exerts anti-tumour growth effects by antagonising the effects of HGF and its receptor, cMET, in human lung cancer cells

Por Jiang, Wen G., Ye, Lin, Ruge, Fiona, Owen, Sioned, Martin, Tracey, Sun, Ping-Hui, Sanders, Andrew J., Lane, Jane, Satherley, Lucy, Weeks, Hoi P., Gao, Yong, Wei, Cong, Wu, Yiling, Mason, Malcolm D.
Publicado no J Transl Med (2015)

Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer

Por Owonikoko, Taofeek K., Zhang, Guojing, Kim, Hyun S., Stinson, Renea M., Bechara, Rabih, Zhang, Chao, Chen, Zhengjia, Saba, Nabil F., Pakkala, Suchita, Pillai, Rathi, Deng, Xingming, Sun, Shi-Yong, Rossi, Michael R., Sica, Gabriel L., Ramalingam, Suresh S., Khuri, Fadlo R.
Publicado no J Transl Med (2016)

Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic...

Por Rüttinger, Dominik, van den Engel, Natasja K, Winter, Hauke, Schlemmer, Marcus, Pohla, Heike, Grützner, Stefanie, Wagner, Beate, Schendel, Dolores J, Fox, Bernard A, Jauch, K-W, Hatz, Rudolf A
Publicado em 2007

Quantitative proteomics analysis of mitochondrial proteins in lung adenocarcinomas and normal lung tissue using iTRAQ and tandem mass spectrometry

Por Li, Wei, Zhang, Xuede, Wang, Wei, Sun, Ruiying, Liu, Boxuan, Ma, Yuefeng, Zhang, Wei, Ma, Li, Jin, Yaofeng, Yang, Shuanying
Publicado no Am J Transl Res (2017)

Inhibition of AMPK-related kinase 5 (ARK5) enhances cisplatin cytotoxicity in non-small cell lung...

Por Li, Minghui, Zheng, Chengfei, Xu, Hongfei, He, Wei, Ruan, Yongchun, Ma, Jianyong, Zheng, Junnan, Ye, Chengmeng, Li, Weidong
Publicado no Am J Transl Res (2017)

Improved survival with stereotactic ablative radiotherapy (SABR) over lobectomy for early stage non-small cell lung cancer (NSCLC): addressing the fallout of disruptive randomized data

Por Rusthoven, Chad G., Kavanagh, Brian D., Karam, Sana D.
Publicado no Ann Transl Med (2015)

Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in Non-Small Cell Lung Cancer

Por Baratelli, Felicita, Takedatsu, Hiroko, Hazra, Saswati, Peebles, Katherine, Luo, Jie, Kurimoto, Pam S, Zeng, Gang, Batra, Raj K, Sharma, Sherven, Dubinett, Steven M, Lee, Jay M
Publicado em 2008

O10. Allele-specific real-time PCR detection of EGFR exon 19 and 21 mutations in various clinical non-small cell lung cancer specimens

Por Skronski, Michal, Szpechcinski, Adam, Langfort, Renata, Jagus, Paulina, Gizycka, Agata, Maszkowska-Kopij, Krystyna, Orlowski, Tadeusz, Roszkowski-Sliz, Kazimierz, Chorostowska-Wynimko, Joanna
Publicado no Transl Lung Cancer Res (2014)

The Pulmonary Fibrosis Associated MUC5B Promoter Polymorphism Is Prognostic of the Overall Survival in Patients with Non–Small Cell Lung Cancer (NSCLC) Receiving Definitive Radiotherapy()()()

Por Yang, Ju, Xu, Ting, Gomez, Daniel R., Jeter, Melenda, Levy, Lawrence B, Song, Yipeng, Hahn, Stephen, Liao, Zhongxing, Yuan, Xianglin
Publicado no Transl Oncol (2017)

Evaluation of rare but severe immune related adverse effects in PD-1 and PD-L1 inhibitors in non-small cell lung cancer: a meta-analysis

Por Hu, Yang-Bo, Zhang, Qun, Li, Hui-Juan, Michot, Jean Maire, Liu, Hong-Bing, Zhan, Ping, Lv, Tang-Feng, Song, Yong
Publicado no Transl Lung Cancer Res (2017)

24h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profiling

Por Baty, Florent, Joerger, Markus, Früh, Martin, Klingbiel, Dirk, Zappa, Francesco, Brutsche, Martin
Publicado no J Transl Med (2017)

Italian multicenter survey to evaluate the opinion of patients and their reference clinicians on the “tolerance” to targeted therapies already available for non-small cell lung cancer treatment in daily...

Por Novello, Silvia, Capelletto, Enrica, Cortinovis, Diego, Tiseo, Marcello, Galetta, Domenico, Valmadre, Giuseppe, Casartelli, Clelia, Rapetti, Simonetta Grazia, Rossi, Antonio
Publicado no Transl Lung Cancer Res (2014)

Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy

Por Castañon, Eduardo, Bosch-Barrera, Joaquim, López, Inés, Collado, Víctor, Moreno, Marta, López-Picazo, José María, Arbea, Leire, Lozano, María Dolores, Calvo, Alfonso, Gil-Bazo, Ignacio
Publicado em 2013